Massachusetts General Hospital × Adhd
Massachusetts General Hospital adhd: 6 indexed trials, 2 recruiting studies across 1 countries in the current NeuroRisk corpus.
Request comparative brief →Indexed trials6
Recruiting2
Countries1
Indexed studies
NCT01721330A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
United StatesPHASE4
United StatesPHASE4
NCT02536105PK/PD Pediatric ADHD Classroom Study
United StatesNA
United StatesNA
NCT01075672Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
United StatesNA
United StatesNA
NCT01246765National Pregnancy Registry for Psychiatric Medications
United StatesRECRUITING
United StatesRECRUITING
NCT00181792Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
United StatesCOMPLETED
United StatesCOMPLETED
NCT01873729An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
United StatesPHASE4
United StatesPHASE4
Enterprise comparison
Compare sponsor momentum, recruiting activity, geography and connected evidence with the broader NeuroRisk intelligence layer.
Request enterprise access →